US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Checkpoint Therapeutics Inc (CKPT)
Checkpoint Therapeutics Inc (CKPT) ニュース

CKPT

Checkpoint Therapeutics (CKPT)

Checkpoint Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CKPT

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/25	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/25	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/25	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/25	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/25	05 : 06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/17	08 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/14	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/11	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/05/10	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/03/02	10 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/02/06	07 : 00	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/02/03	10 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/02/03	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/01/31	07 : 10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/01/31	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2024/01/06	07 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/12/18	21 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/11/27	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/11/18	07 : 02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/11/18	07 : 01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/11/14	07 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/11/14	07 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/10/04	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/08/15	05 : 36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/08/15	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/08/15	05 : 01	GlobeNewswire Inc.	Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/07/31	21 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/07/31	21 : 23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/07/27	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CKPT	Checkpoint Therapeutics Inc
2023/05/25	06 : 26	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CKPT	Checkpoint Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:CKPT

1 2 3 4 5 6 7 次へ >>

BNP Paribas (QX)

Verizon Communications

Deutsche Telekom (QX)

American Express

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約